Other languages Immuron Limited

Equities

Market Closed - Australian S.E. Other stock markets 02:10:44 2024-04-26 am EDT			5-day change	1st Jan Change
0.105 ^AUD	0.00%		+5.00%	+36.36%

Apr. 10	Immuron Limited Provides Sales Results for the Quarter and Year to Date Ended March 2024	CI
Apr. 10	Immuron's Global Sales Climb 51% in March Quarter; Shares Surge 18%	MT

Immuron's Global Sales Climb 51% in March Quarter; Shares Surge 18%	Apr. 09
Sector Update: Health Care Stocks Gain Late Afternoon	Mar. 07
Sector Update: Health Care	Mar. 07
Top Midday Gainers	Mar. 07
Top Premarket Gainers	Mar. 07
Immuron Moving Anti-Diarrhea Drug to Phase Three Trials	Mar. 07
Immuron Limited Announces Positive Results Support Travelan Progress to Phase 3 Clinical Trials in the US	Mar. 07
Immuron Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 27
Immuron Posts Record Travelan Sales in Fiscal H1	Jan. 16
Immuron Limited Clinical Trials Update	Dec. 22
Immuron Announces First Patients Enrolled in Campylobacter Challenge Clinical Study	Dec. 04
Immuron Limited Announces Travelan® Clinical Study Cohort 2 Commences	23-10-18
Immuron Reports Big Jump in Fiscal Q1 Travelan Sales	23-10-11
Immuron Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-29
Immuron Limited Receives TGA GMP Clearance	23-08-09
Immuron Secures Clearance for Packaging of Immunotherapy Product; Shares Surge 27%	23-08-09
Immuron Says First Patients Enrolled in Travelan Trial	23-07-25
Immuron Limited Announces First Patients Enrolled in Travelan® Clinical Study	23-07-25
Immuron Enrolls First Patients in Travelan Clinical Study	23-07-25
Immuron Posts 136% Jump in Fiscal 2023 Sales of Travelan, Protectyn Supplements	23-07-05

No results for this search